AI Bias Analysis
4 models · Takes ~15 seconds
FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat depression.
Source
Stat News
Opens original article in a new tab
The state of Covid-19 in 2026, a hat to treat depression, and other health news from Morning Rounds
With good results from Intellia, the CRISPR field faces the question: How attractive will the one-and-done approach be to patients and doctors?
A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical trial, its maker, Oruka Therapeutics, reported.
The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.
